A. Zmysłowski, et al.
FoodChemistry329(2020)127132
2.4.2. HPLC method for 3β,3′β-disteryl ether synthesis optimization
The synthesis optimization was conducted using a Thermo Scientific
Accela Model 430 bar liquid chromatograph, an autosampler (10 °C), a
thermostat for the column (25 °C), and a diode array detector (DAD,
210 nm). 3β,3′β-Dicholesteryl ether was separated on Zorbax Si
250x4.6 mm 5 µm using n-Hep as the mobile phase. The sample was
dissolved in 1 mL of n-Hep after the evaporation of the reaction solvent.
The injection volume was 5 µL.
system was applied: 0–2 min 0% B, 2–10 min 0–60% B, 10–12 min 60%
B, and 12–15 min 0% B (balancing the column until the initial condi-
tions are restored). Chromatographic separation was conducted with a
constant flow of the mobile phase (400 µL/min) at a temperature of
35 °C.
2.5. NMR spectroscopy
The NMR spectra were recorded at 298 K by either a Varian
VNMRS-500 or Varian VNMRS-600 spectrometer that was equipped
with a 5-mm Z-SPEC Nalorac IDG 500-5HT gradient probe or a 5-mm
PFG AutoXID (1H/X15N-31P) probe, respectively. Standard pulse se-
quences were used. The structures of the studied steroids were de-
termined via analysis of homonuclear (DQF-COSY, zTOCSY, and
NOESY) and heteronuclear (1H−13C HSQC, HSQC-TOCSY, and HMBC)
spectra. The 1H connectivities were established via analysis of the DQF-
COSY and TOCSY spectra. The resonances of all carbons with directly
attached protons were assigned using the HSQC and HSQC-TOCSY
spectra. Then, the HMBC spectra were used to assign the quaternary
carbon resonances and to evaluate the correctness of the connectivities
that were established via the analysis of the other spectra. NOESY
spectra were also utilized to establish the α/β deuterations of steroids
10–15.
2.4.3. Preparative separation of 3β,3′β-disteryl ether
Preparative chromatography was conducted using
a LC-20
Prominence (Shimadzu) system, which consisted of a pump, an auto-
sampler (ambient temperature), a thermostat for the column (25 °C), a
diode array detector (DAD, 210 nm) and a fraction collector. 3β,3′β-
Disteryl ethers were separated on a silver-impregnated silica column,
namely, Zorbax Si of dimensions 250 × 4.6 mm 5 µm, using 0,20%
MTBE in n-Hep. The major fractions were collected into separate col-
lector vials. After several injections and runs, the organic solvents in the
collected fractions were removed by a gentle nitrogen stream with no
heat.
2.4.4. GC–MS method for 3β,3′β-disteryl ethers
A Shimadzu GC-2010 Plus with an Optic-4 autosampler that was
coupled with an MS-TQ8050 mass spectrometer was used. 3β,3′β-dis-
teryl ethers were separated on ZB-1HT of dimensions 30 m × 0.25 mm
with a film thickness of 0.1 μm. The carrier gas was helium with an inlet
pressure of 318 kPa and a flow rate of 68.6 cm/s. The initial column
temperature of 280 ˚C was held for 2 min and increased by 10 °C/min to
390 °C, where it was held for 10 min. Injections (20.0 µL) were con-
ducted in a split program mode (Table S7). The injector temperature
was 70 °C for 45 s, with the solvent valve open, which was increased
with a temperature gradient of 40 °C/s to 360 °C. The transfer line
temperature was 325 °C, the ion source temperature was 280 °C and the
energy of the electron impact ionization was 70 eV. The 3β,3′β-disteryl
ethers were analysed using selected ion monitoring (SIM). For 3β,3′β-
dicholesteryl ether, 369 m/z were monitored, for 3β,3′β-distigmasteryl
ether 394 m/z and for 3β,3′β-disitosteryl ether 397 m/z.
The experiments were conducted under the following conditions:
DQF-COSY - spectral widths of 5000 Hz in both dimensions, 4096
complex points in t2, 1024 complex points in t1, 1 scan per increment,
and a relaxation delay of 1 s; TOCSY - spectral widths of 5000 Hz in
both dimensions, 2048 complex points in t2, 1024 complex points in t1,
2 scans per increment, a relaxation delay of 1 s and a spin-lock time of
20 ms; NOESY - spectral widths of 5000 Hz in both dimensions, 1024
complex points in t2, 512 complex points in t1, 4 scans per increment, a
relaxation delay of 1 s and a mixing time of 400 ms; 1H–13C HSQC -
spectral widths of 5000 Hz in F2 and 19000 Hz in F1, 1024 complex
points in t2, 512 complex points in t1, 2 scans per increment, and a
relaxation delay of 1 s; 1H–13C HSQC-TOCSY - spectral widths of
5000 Hz in F2 and 15000 Hz in F1, 1024 complex points in both di-
mensions, 2 scans per increment, a relaxation delay of 1 s and a spin-
lock time of 18 ms; and 1H–13C HMBC - spectral widths of 5000 Hz in
F2 and 25000 Hz in F1, 1024 complex points in both dimensions, and 4
scans per increment.
2.4.5. Method validation
The method validation was described in previous works (Szterk,
(LOQ) were calculated based on the standard deviation of the response
and the slope of the analytical curve. Recovery tests were conducted
using three concentration levels: low concentration (25 ng/mL),
medium concentration (100 ng/mL) and high concentration (250 ng/
mL)
which was followed by zero-filling in both dimensions. Gaussian
weighting functions were applied in both domains prior to Fourier
transformation.
Prior to the analysis, 10 to 20 mg of the samples were dissolved in
600 µL of deuterated chloroform‑d1.
2.4.6. LC-QTOF-MS methods
2.6. Biological studies
A
UHPLC Ultimate 3000 (Dionex Thermo Fisher Scientific,
Sunnyvale, California, USA) system, which consisted of a pump, a de-
gasser, an autosampler, and a column heater instrument, was used.
Data processing was conducted with Chromeleon 6.8 and Chromeleon
Validation ICH software (Dionex). To determine the peak elution order,
2.6.1. Cell culture
Endothelial cells were grown in a medium that consisted of the
following for the in vitro culture congaing: EGF, FGF-2, VEGF, vitamin
C, R3-IGF-1, 3% FBS, gentamycin/amphotericin, hydrocortisone, and
heparin. The cells were kept in a 37 °C incubator with 95% humidity
and 5% CO2.
a
mass spectrometer maXis 4G from Bruker Daltonic (Billerica,
Massachusetts, USA) was used. The QTOF settings were as follows: at-
mospheric pressure chemical ionization (APCI) in positive ion mode,
nebulizer 2.0 bar, dry gas (nitrogen) flow rate of 4.0 L/min, dry heater
at 200 °C, vaporizer temperature 450 °C, capillary voltage of 3000 V,
corona discharge 3000nA and end plate offset of −500 V. The MS data
were recorded in full scan mode (from 100 to 1600 m/z). The mass
spectrometer was used in high-resolution mode (R = 60000), and an
internal calibrant (APCI/APPI calibrant) was used to obtain a precise
mass measurement. Chromatographic separation was conducted using a
Zorbax XBD-C18 50 × 2.1 mm with a 1.8 µm particle size in a gradient
system (phase A: MeOH, phase B: CH2Cl2). The following gradient
2.6.2. Liposome preparation
The DOPC: 3β,3′β-disteryl ether: DSG-PEG 2000 with a molar ratio
of 3:1:0.3 was dissolved in CHCl3, a Rotavapor was used to evaporate
the solvent, and the thin lipid film was rewetted in 10 mL of the culture
medium. The liposomes were prepared using ultrasound and an ex-
trusion method that utilized nylon membranes (10 µm, 0.45 µm, and
0.22 µm).
The control liposomes and the liposomes that contained 7-kCh (22)
were prepared via the same approach by exchanging the 3β,3′β-disteryl
4